Skip to main content
60°
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich Pendulum
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
Classifieds
Place ad
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Community Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Harrow, Inc.
Harrow Announces Second Quarter 2024 Financial Results
August 07, 2024
From
Harrow, Inc.
Via
Business Wire
Tickers
HROW
Harrow To Report Second Quarter 2024 Financial Results After Market Close on August 7, 2024
July 25, 2024
From
Harrow, Inc.
Via
Business Wire
Tickers
HROW
Harrow to Attend 2024 ASRS Annual Meeting
July 12, 2024
From
Harrow, Inc.
Via
Business Wire
Tickers
HROW
Harrow Enters into 340B Prime Vendor Program Contract with Apexus™ for IHEEZO® and Other Key Harrow Products
July 09, 2024
From
Harrow, Inc.
Via
Business Wire
Tickers
HROW
Harrow Provides TRIESENCE® Relaunch Update
June 20, 2024
From
Harrow, Inc.
Via
Business Wire
Tickers
HROW
Harrow Announces 52-Week Data from VEVYE® ESSENCE-2 Open-Label Extension Study
June 05, 2024
From
Harrow, Inc.
Via
Business Wire
Tickers
HROW
Harrow to Present at Two Investor Conferences in May
May 15, 2024
From
Harrow, Inc.
Via
Business Wire
Tickers
HROW
Harrow Announces First Quarter 2024 Financial Results
May 13, 2024
From
Harrow, Inc.
Via
Business Wire
Tickers
HROW
Harrow Names Greg DiPasquale as Senior Vice President, Head of Commercial
May 13, 2024
From
Harrow, Inc.
Via
Business Wire
Tickers
HROW
Harrow Will Release First Quarter 2024 Financial Results After Market Close on May 13, 2024
April 25, 2024
From
Harrow, Inc.
Via
Business Wire
Tickers
HROW
Harrow Announces Fourth Quarter and Year-End 2023 Financial Results
March 19, 2024
From
Harrow, Inc.
Via
Business Wire
Tickers
HROW
Harrow Will Release Fourth Quarter and Year-End 2023 Financial Results After Market Close on March 19, 2024
March 05, 2024
From
Harrow, Inc.
Via
Business Wire
Tickers
HROW
Harrow Licenses Canadian Rights to Apotex for Five Branded Ophthalmic Pharmaceutical Products
February 15, 2024
From
Harrow, Inc.
Via
Business Wire
Tickers
HROW
Harrow Announces New Appointments to its Board of Directors
January 29, 2024
From
Harrow, Inc.
Via
Business Wire
Tickers
HROW
Harrow Announces Availability of VEVYE® (Cyclosporine Ophthalmic Solution) 0.1%, the First and Only Cyclosporine-Based Product Indicated for Treating Both Signs and Symptoms of Dry Eye Disease
January 11, 2024
From
Harrow, Inc.
Via
Business Wire
Tickers
HROW
Harrow Partners with Leading Healthcare Market Access Technology Platforms
January 03, 2024
From
Harrow, Inc.
Via
Business Wire
Tickers
HROW
Harrow Completes Transfer of the TRIESENCE® New Drug Application
November 29, 2023
From
Harrow, Inc.
Via
Business Wire
Tickers
HROW
Harrow to Present at Two Investor Conferences in November
November 20, 2023
From
Harrow, Inc.
Via
Business Wire
Tickers
HROW
Harrow Announces Third Quarter 2023 Financial Results
November 13, 2023
From
Harrow, Inc.
Via
Business Wire
Tickers
HROW
Harrow Will Release Third Quarter 2023 Financial Results on November 13, 2023
October 30, 2023
From
Harrow, Inc.
Via
Business Wire
Tickers
HROW
Harrow Completes Transfer of NDAs and Launches FLAREX®, NATACYN®, TOBRADEX® ST, VERKAZIA®, and ZERVIATE® in the U.S.
October 24, 2023
From
Harrow, Inc.
Via
Business Wire
Tickers
HROW
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.